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http://www.biomedcentral.com/1471-2474/14/163RESEARCH ARTICLE Open AccessPatient perspectives of managing fatigue in
Ankylosing Spondylitis, and views on potential
interventions: a qualitative study
Helen Davies1*, Sinead Brophy1, Michael Dennis1, Roxanne Cooksey1, Elizabeth Irvine1 and Stefan Siebert2Abstract
Background: Fatigue is a major component of living with ankylosing spondylitis (AS), though it has been largely
over-looked, and currently there are no specific agreed management strategies.
Methods: This qualitative exploratory study involved participants who are members of an existing population-
based ankylosing spondylitis (PAS) cohort. Participants residing in South West Wales were invited to participate in a
focus group to discuss; (1) effects of fatigue, (2) self-management strategies and (3) potential future interventions.
The focus groups were audio-recorded and the transcripts were analysed using thematic analysis.
Results: Participants consisted of 3 males/4 females (group 1) and 4 males/3 females (group 2), aged between 35
and 73 years (mean age 53 years). Three main themes were identified: (1) The effects of fatigue were multi-
dimensional with participants expressing feelings of being ‘drained’ (physical), ‘upset’ (emotional) and experiencing
‘low-mood’ (psychological); (2) The most commonly reported self-management strategy for fatigue was a balanced
combination of activity (exercise) and rest. Medication was reluctantly taken due to side-effects and worries over
dependency; (3) Participants expressed a preference for psychological therapies rather than pharmacological for
managing fatigue. Information on Mindfulness-Based Stress Reduction (MBSR) was received with interest, with
recommendations for delivery in a group format with the option of distance-based delivery for people who were
not able to attend a group course.
Conclusions: Patients frequently try and manage their fatigue without any formal guidance or support. Our
research indicates there is a need for future research to focus on psychological interventions to address the
multi-faceted aspects of fatigue in AS.Background
Fatigue affects those in poor and good health and is a
multi-determined phenomenon [1]. In healthy individ-
uals it is normal and temporary whereas disease-related
fatigue is dysfunctional, longer-lasting or chronic and
persists despite adequate periods of rest and sleep [2-4].
Fatigue is a significant component of many chronic in-
flammatory conditions [1].
Historically, fatigue associated with ankylosing spondylitis
(AS) has received little attention. [5]. However, more recent
studies have now demonstrated that over half of people with
AS experience this debilitating phenomenon [5-8], with fa-
tigue now accepted as a core symptom of the condition.* Correspondence: h.davies@swansea.ac.uk
1College of Medicine, Swansea University, Swansea, South Wales, UK
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reproduction in any medium, provided the orThe fatigue experienced by people with AS is reported
to be related to disease activity [5,9-12], poorer func-
tional ability [5,10,12,13], pain [5,13,14] and stiffness
[5,10,13] mental health problems [9,11,13] such as de-
pression [11], lower global well-being [10,13], impaired
working [13] and enthesitis [10]. Understandably, due to
the symptoms experienced, an additional factor associ-
ated with AS-related fatigue is sleep. Studies report that
more than half of individuals with AS have sleep disor-
ders related to fatigue [7,11,14].
Amitriptyline medication is often prescribed for fa-
tigue management in AS [5], and current guidelines
from the National Institute for Health and Care Excel-
lence (NICE) recommend utilising psychological inter-
ventions to help in the management of inflammatory
arthritis [15].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perspective (i) the effect of fatigue in AS with a focus on
(ii) ways of self-managing fatigue as part of their every-
day lives, and (iii) to identify potential interventions for
future research to help combat fatigue in AS.
Method
This study builds on our existing Population-based Anky-
losing Spondylitis (PAS) cohort study that currently in-
volves 500+ participants with AS. The protocol for the
development of the cohort has previously been published
[16]. Briefly 500+ patients with AS residing in Wales, UK
were recruited between 2008 and 2011 and were sent
questionnaires every 3 months to examine disease activity
(including pain and fatigue), function, medication, and
quality of life. Respondents were asked specific questions
about flares, exercise, work, health care costs, and coping
with AS. Two open-ended questions (essay type) were in-
cluded in the questionnaire exploring the individual’s ex-
perience of fatigue and personal management strategies.
Following on from this quantitative study [17] which iden-
tified that management strategies for fatigue in AS should
focus on pain management including psychological inter-
ventions, we wanted to conduct focus groups with people
with AS to further explore potential management strat-
egies for fatigue in AS, to help inform our research agenda
for potential future research activity stemming from the
patients’ perspective.
Focus groups are advantageous for data collection, as
group interaction enhances the depth of conversation
due to stimulation of thoughts from other group mem-
bers, and responses can be shared and compared [18].
Ethics
The PAS study received ethical approval from the
London Multi-centre Research Ethics committee and
participants gave written consent in accordance to the
Declaration of Helsinki. Approval for the focus groups
was obtained from the same Ethics committee via a sep-
arate substantial amendment.
Participants
Participants (n = 102) in the PAS cohort study resident
in the catchment area for the Abertawe BroMorgannwg
University Health Board (ABM UHB) Wales, UK were
sent an invitation pack, which included an invitation let-
ter, information sheet, focus group schedule expression
of interest (EOI) form, and consent form. The locality of
ABM UHB was chosen as Swansea is Wales’ second lar-
gest city and its population diverse. Latest figures shown
that Swansea has a population of 229,100 [19] and in
terms of employment, Swansea has the second most de-
prived and the least deprived areas in Wales [20].Focus groups
Two focus groups were conducted in October 2011 in
local venues (hotels) in the locality of ABM UHB. The
focus groups lasted approximately 1 hour 45 minutes.
One researcher (HD) moderated the focus group discus-
sion, and one project assistant (EI) provided technical
support and participant observation (note taking of non-
verbal communication).
In order to assess if participants in the focus groups
were representative of other people with AS we compared
characteristics (age, gender, disease duration and fatigue
levels) of participants who attended a focus group from
ABM UHB (n = 14) with (i) all PAS participants (n = 533),
and (ii) PAS participants from ABM UHB who declined to
participate in the focus group (n = 18).
Focus group schedule
The focus group schedule was developed using broad
topic areas which complemented and lead on from two
original open-ended questions in a previous PAS study
questionnaire on fatigue [17]. Consideration was also
given to existing literature, and current clinical practice in
relation to managing fatigue in AS. We wanted to specific-
ally explore views and experiences of two diverse strategies
for managing fatigue; medication and psychological inter-
ventions. Representing these avenues for discussion we
choose amitriptyline (medication), and Mindfulness-Based
Stress Reduction (MBSR) (psychological intervention) re-
spectively. The rationale being amitriptyline is frequently
prescribed for people with AS and has been shown to im-
prove fatigue [5], and the NICE guidelines (2009) recom-
mend that people with inflammatory arthritis should be
offered access to psychological interventions to help man-
age their condition [15]. In particular, MBSR has been
found to be beneficial for chronic pain [21] which is key
for the management of fatigue [17]. Participants in this
study were encouraged to discuss other treatments for fa-
tigue which fall between the two diverse strategies chosen,
thus providing an open forum in which to explore other
management strategies of interest to help inform future
research. The focus group schedule was flexible to encour-
age a broad spectrum of participant’s views. All partici-
pants were sent the focus group schedule at least 3 weeks
in advance.
Data management and data analysis
Each focus group session encompassed interaction and re-
sponses between participants and moderator which were
recorded and transcribed verbatim in Microsoft Word.
Each verbatim transcription then served as a primary text
document. Using a qualitative thematic analyses [22] each
primary document was read several times by (HD and SB)
to gain theoretical sensitivity which emphasises the partic-
ipants’ frame of mind [23]. A researcher (HD) used open
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tempt to encapsulate participants’ meaning. Another re-
searcher (SB) checked the codes for accuracy and
consistency with no discrepant codes identified. Related
and reoccurring codes were grouped together to form main
themes and specific quotations from the primary docu-
ments were highlighted to illustrate the salient themes.
Personal data generated from this study was anonymised
using unique identification numbers and all paper data
was securely stored in locked cupboards and electronic
data in password protected files on a secure university
server.
Results
Of 102 invitations sent, 45 (46%) potential participants
returned the EOI form with 24/45 (53%) expressing
interest in participating in a focus group. 18/45 (40%)
were not interested (declined) and 3/45 (7%) returned a
blank EOI form. Reasons for not participating in this
study included, ill-health, being a full-time carer and not
wanting to join a group discussion. 14/24 (58%) who
expressed an interest, participated in one of the two
focus groups. 10/24 (42%) were not available on the
dates selected for the focus groups. All participants (n =
14, 7 male) had a clinical diagnosis of AS with an aver-
age disease duration (based on date of diagnosis) of
29 years (range 8–46 years). Participants consisted of 3
males/4 females (group 1) and 4 males/3 females (group
2), aged between 35 and 73 years (mean age 53 years).
All participants were Caucasian. One participant (1/14)
was on a tumor necrosis factor (TNF) blocker.
The characteristics of the participants who attended
the focus groups (n = 14) were comparable with those
who declined (n = 18) and comparable to the population
from which they were selected (all PAS participants (n =
533)) for age: mean age was 50, 49 and 53 years, respect-
ively. Disease duration: was slightly longer (29 years) in
the focus group participants compared with 18 years
and 22 years, for declined and population, respectively.
However, the percentage of females appeared higher for
those attending the focus group 50% (7/14) compared to
the population, 25% (134/533). In addition, the fatigue
levels appeared higher in the focus group participants
72% (10/14) compared to those who declined to partici-
pate 50% (9/18).
This study identified 3 main themes; [1] Pervasive fa-
tigue; [2] current limitations (of self-management); and
[3] a new direction (for future interventions).
(1)Pervasive fatigue
Participants reported many ‘life’ influences which exac-
erbated or contributed to feelings of fatigue including; age,
lack of sleep, night time pain, low-mood, depression, lackof concentration, side effects from medication, work com-
mitments and the unpredictability of the condition. One
participant felt it was difficult to distinguish ‘age-related’
symptoms from fatigue in AS “I nod off in the chair, but
that’s not fatigue, that is just getting old and getting tired”.
Other participants make a clear distinction that fatigue is
exacerbated by lack of sleep caused by pain “I can’t re-
member ever having a good night’s sleep. I wake up con-
stantly every couple of hours through pain, I never sleep
through, so I am constantly tired”, which in turn causes
physical symptoms such as “a burning sensation with your
eyes when you are really tired”.
The majority of participants expressed that side-effects
from analgesic medication also contributed to feelings of
fatigue with many participants expressing concern that
their medication was adding to their fatigue “I always
put it [fatigue] down to my pain and then I wasn’t sure if
it was the medication…other members of my family also
take high doses of co-codamol and it sends them to
sleep…” Also, fatigue is unpredictable “you can get this
tiredness for no reason. It just comes on you…” whereas
another participant implied “I never found that I was
tired generally, only after a flare up.”
Work commitments were on one hand viewed as a mo-
tivator for life, one participant said “it [job] keeps me go-
ing”, but alternatively another participant who finished
work due to fatigue in AS stated “I have finished work now
so I am managing much better, but when I was working I
found it very hard, you could just cry or you felt physically
sick because you felt so tired.” In agreement one partici-
pant stated “In the end I just gave up work…it made it eas-
ier physically not having to go in, but I still find I am
having periods of mood swings and depression…the longer
it [sleep problems] goes on then the more mood swings kick
in.” Another participant found it “hard to concentrate in
work because you felt so tired.”
There was a general consensus over the uncertainty of
whether the symptoms of AS (such as pain, impaired sleep)
caused fatigue or if fatigue was a symptom of AS. One par-
ticipant questioned “Has the humira [adalimumab] helped
me with the fatigue or has it helped with my sleeping pat-
tern which has indirectly helped with my fatigue?”.
The next theme highlights self-management interven-
tions used by participants including experiences and
challenges.
(2)Current limitations (of self-management)
Participants were encouraged in the focus group to dis-
cuss what interventions or treatments they had tried, or
wanted to try with regard to self-managing their fatigue.
Responses ranged from; having a positive attitude “just
keep on going” and “trying to see the glass half full not half
empty”, self-medication “I will take more co-codamol”,
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dogs, I swim and I keep active”, and being a member of a
gym. Hydrotherapy was a popular activity, but finding a
warm pool and the cost involved were viewed as problem-
atic “it would be lovely to swim in a warm pool but the
prices these places are charging.” One participant stated
they felt they “had to exercise that was the leveller…..if I
don’t do it [exercise] I am in real trouble.” Other partici-
pants reported sleeping for short periods of time “a 10 mi-
nute power nap and I am fine again”.
Some participants implied they tried not to rely on
medication for managing their AS due to the many side-
effects experienced. The following quote illustrates this
situation: “I was taking indomethacin for the pain but it
caused the bowel to flare up and I was hospitalised with
that….so I try and manage without drugs if I can…but of
course you have to if the pain is very bad.”
As part of the focus group participants were shown a
3 minute video clip on amitriptyline medication [24]
(which can be prescribed before bedtime for fatigue and
pain in chronic musculoskeletal conditions), including how
it works, dosage and its advantages for managing chronic
nerve pain. Four out of 14 participants had used with this
type of medication previously. Ten participants had no pre-
vious knowledge “I have never heard of it”. Participants
who had taken amitriptyline complained of side-effects “…
I took it for a couple of months…..it just made me feel like a
zombie…I felt worse”. Another participant experienced a
dry mouth and feeling drowsy in the morning. One partici-
pant who had taken amitriptyline for over 2 years reported
no side-effects but implied the drug made no difference to
her symptoms “I honestly don’t see any difference really, I
mean I was wandering around at 3 o’clock this morning…I
couldn’t sleep…”. The fourth participant with experience of
amitriptyline stated she was wary of taking an antidepres-
sant “It frightened me a bit when they [rheumatologist]
mentioned antidepressant….I thought that it might be ad-
dictive but I didn’t know so I took it for a week then I
stopped just in case I got addicted to it.”
A few participants had tried alternative or complemen-
tary interventions for managing fatigue. One participant
tried meditation guided by an occupational health ad-
visor which was “lovely” but not very useful when experi-
encing a flare “I didn’t find that really very good for
when you are having a bad time which is really when I
thought it would be.” Acupuncture, TENS machines and
heat wraps were described as “pleasant”, but provided
only “temporary” pain relief. One participant suggested
that breathing exercises “worked if you had real acute
pain and you tried to focus on your breathing”. Yoga and
Pilates activity seemed to be avoided due to fear of “over
doing it” especially during a “flare-up”.
(3)A new direction (for future interventions)Participants were also shown a 3 minutes video clip on
MBSR [25], a psychological intervention which has been
shown to have physical and psychological benefits in nu-
merous health conditions [26] and was originally devel-
oped for managing chronic pain [27]. None of the
participants had heard of MBSR and only one had tried
a psychological intervention (cognitive behaviour ther-
apy – CBT) for depression and anxiety, rather than
management of fatigue in AS.
The majority of participants in this study were open to
trying MBSR and many requested more information about
available courses. The following quotes illustrate this: One
participant stated “You never know with these things [psy-
chological interventions] sometimes they work and some-
times they don’t but it is well worth trying isn’t it really.”
Another participant commented, “I think it [MBSR] is
something that I would like to try… I would give it a go”.
Several participants appeared very enthusiastic expressing
“I would like some more information about this” and “If
there was a chance for me to go on a course I would go”
and “I would be very happy in experiencing that sort of
technique.” It was also suggested that MBSR should be
available to significant others or carers of the person with
AS, with one participant saying “I think my wife would
benefit from it and her stress levels…”
The group discussion evolved towards the different deliv-
ery modes of MBSR which is traditionally delivered in a
weekly group session of 2.5 hours over 8 consecutive weeks.
Other potential modes of deliver explored included on-line
courses and distance delivery over the telephone with a
similar time delivery (over 8 weeks). Most participants in
this study expressed a preference for the traditional group
structure rather than on-line or distance delivery.
However, reasons were put forward to advocate the MBSR
delivery method to fit the needs of the individual: “When I
was working I would have found it difficult to commit to
1 day a week for 8 weeks, so the distance delivery might be
better.” And another participant commented “There will al-
ways be people that don’t want to talk about it to another
person” and “there would have to be something that would
suit all people not just one thing (one delivery mode)”.
When probed for future research ideas for fatigue in
AS it became apparent that most participants wanted
more ‘alternative’ or ‘psychological therapy’ interventions
funded rather than focusing on more drug trials and re-
search into orthodox medication. The following quotes
illustrate this view: “I think there is a lot of research
when it comes to drugs in AS and there is not a lot of re-
search which it comes to alternative therapies” and “I
think the answer is to research different things”
Discussion
To our knowledge this is the first qualitative study explor-
ing management strategies for fatigue from the patient
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outlined in the schedule with participants first discussing
the perception and lived-experience of fatigue in AS. The
participants in this study appear to experience fatigue on a
daily basis but they remained unsure as to whether the
symptoms of fatigue was a component of the condition it-
self, or whether the fatigue experienced was a result of
having disturbed sleep due to chronic pain. The general
consensus in the literature is that fatigue is a feature of in-
flammatory conditions, including AS [1,28,29]. Other
studies [11,17,30,31], indicate that pain is the most power-
ful predictor of fatigue. More recently an editorial on fa-
tigue in rheumatoid arthritis concluded that the mediation
of fatigue relates more to psychological and physical fac-
tors such as anxiety, depressive symptoms, pain disability
and sleep disturbances and much less to the consequences
of the disease process [32]. However, a conceptual model
encompassing factors related to disease process, cognitive/
behavioural and personal life issues has been proposed for
rheumatoid arthritis [28].
Regardless of the origin, fatigue is an issue for many
patients with AS [6-8,30,33,34], with self-management
strategies being advocated for optimal functioning and
daily living [35]. Our study highlights the universal, yet
individual and subjective experience of fatigue in AS.
Participants managed their pain by self medicating
which often proved (i) limited or ineffective for many
participants, while (ii) others experienced undesirable
side-effects and others (iii) feared over reliance and ad-
diction. The medication consequences often exacerbated
feelings of fatigue and loss of control.
This study also explored how participants currently
managed fatigue and ideas for future strategies. Self-
management of a disease like chronic arthritis has many
facets. The Institute of Medicine in the US defines it as
“relating to the tasks that an individual must undertake
to live well with one or more chronic conditions [36].
These tasks include gaining confidence to deal with
medical management, role management and emotional
management”.
Our participants mainly relied on self-medication, and
a balance of exercise and short periods of sleep ‘nodding
off ’ to help combat the feelings of fatigue. The latter op-
tion was only viable to those participants who had either
retired or were not working. Some participants gave up
employment commitments due to their AS and stated to
be managing their condition and fatigue better since
leaving work, again indicating the role of behavioural
and personal factors on their fatigue.
All participants in this study were ‘happy’ and ‘willing’
to try different interventions to help manage fatigue in
AS including psychological interventions such as MBSR,
and would prefer to integrate alternative and psycho-
logical interventions with traditional medication ratherthan medication on its own. This approach would be con-
sistent with the multi-factorial causative model for fatigue
in inflammatory arthritis [28]. Interestingly, participants
also advocated MBSR for their carers or significant others
to help them deal with the stress of living with someone
with AS. While group-based MBSR was the preferred
method of delivery by participants in this study, it was ac-
knowledged that different delivery modes of MBSR (on-
line, distance delivery) were necessary to reach people with
work or family commitments, and those who do not like
participating in a group environment.
By comparing characteristics of AS participants in our
focus groups with the characteristics of other people
with AS we can suggest that males with AS and with
low levels of fatigue are less likely to attend group work,
hence psychological interventions aimed at this popula-
tion should include a non-group delivery option i.e. indi-
vidual distance delivery. However, people with AS
(including males) and high levels of fatigue appear to ad-
vocate group work.
A limitation of the study is that our two focus groups
might not be representative of the opinions and experi-
ences of all people with fatigue associated with AS. Partici-
pants’ views on preference for MBSR being delivered in a
group may be potentially biased as people who attended
focus groups are more likely to be advocates of group
work. However this qualitative exploratory study (which is
concerned with an in-depth understanding of a topic ra-
ther than the generalizability of findings) is the first study
taken from a patient perspective in this topic area and our
preliminary findings provide insight into potential and fu-
ture management strategies for fatigue in AS.
In addition, we do not know if participants in this study
discussed fatigue with their healthcare providers, but we
do know that participants had unresolved fatigue issues
whether this had previously been discussed or not.
Conclusions
In conclusion, there is currently no specific agreed treat-
ment for the management of fatigue in AS. In the UK,
NICE guidelines (2009) for rheumatoid arthritis it recom-
mends offering access to psychological interventions to
help manage the condition [37], which is also applicable
to AS and other forms of inflammatory arthritis. Quantita-
tive research [17] has shown that fatigue is multidimen-
sional, and this qualitative study from the patients’
perspective has shown support for the use of psychological
interventions for the management of fatigue in AS. Fol-
lowing the findings from our study, our future research
agenda will endeavour to include further studies examin-
ing psychological interventions including MBSR in AS.
The way forward is for the Rheumatology community
to recognise the full impact of fatigue in AS, and em-
brace and refer patients to psychological therapies,
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their role in fatigue as well as being acceptable to pa-
tients who may already be taking several medications for
their underlying condition.
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